Evaluation of usefulness of tongue pressure measurement device for dysphagia associated with treatment of patients with head and neck cancer - ELEVATE

emura Hirokazu0 个研究点目标入组 40 人开始时间: 2022年4月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients with oropharynx or hypopharynx cancer (regardless of tissue system) who undergo chemoradiation treatment or radiation treatment as the first curative treatment. But, patients who have undergone chemotherapy prior to chemoradiation treatment or radiation treatment are included.
•2. Age: 18 to 85 years old
•3. Performance Status (ECOG) is 0 or 1 (within one month prior to obtaining consent)
•4. Patients with written consent for participation of this clinical study from the patient or its representative

•1. Patients whose don't recognize measurer's instructions (e.g. patients with dementia, aphasia, aphasia, higher brain dysfunction, intellectually disabled, etc.)
•2. Patients who can't grip the tongue pressure probe with the front teeth (e.g. patients who are toothless jaws and are not wearing dentures)
•3. Patients who can't crush the tongue pressure probe (e.., patients who cannot move the tongue at all)
•4. Patients with dysphagia du to the pretreatment for head and neck cancer
•5. Patients with significant decrease in swallowing function due to a history of central diseases, etc.
•6. Other patients who are judged inadequate to this research by the principal (sub) investigator

发起方

emura Hirokazu